World nutraceutical demand to balloon
Demand for nutraceutical ingredients is set to take off, with the US remaining the largest single consumer of nutraceutical ingredients and China and Japan emerging as the fastest expanding nutraceutical markets, according to the report entitled “World Nutraceuticals”, issued by Cleveland-based international business research Freedonia Group.
"The industry is characterized in the analysis as being divided among many small members, with only a few market leaders standing out."
"Not only will the Chinese nutraceutical market grow as domestic demand increases, but it will also get more business from the US. "
“…Because of outsourcing trends, the United States will relinquish its longstanding top position in the global production of nutraceutical ingredients to China within the next few years,” says the report.
Read the article...
A new science- Glycobiology has emerged! Eight specific sugars (glyconutrients) have been identified for the support of proper cell structures, processes, and functions (Harper's Biochemistry, 24th ed.). A blend of these eight innate-sugars from plant-rich sources has been developed, along with an entire line of products based on this amazing discovery! Are you ready to rediscover "wellness?"
Sunday, September 10, 2006
Saturday, September 09, 2006
New multi-year funding will allow international group to unravel carbohydrate mysteries
A new multi-year funding will allow this international group to unravel carbohydrate mysteries. The Consortium for Functional Glycomics was formed in response to the NIGMS announcement that it would provide glue grants to support multi-disciplinary, multi-institutional research projects that would be considered beyond the means of any one group. Currently, more than 30 percent of consortium members are from outside the United States, representing more than 25 countries.
"The long-range goal of the Consortium for Functional Glycomics is to fully understand the mechanisms through which carbohydrate-binding proteins mediate cell function and to share that knowledge with other researchers around the world. We know that carbohydrates aid in the proper trafficking of cells in the body, and that they can modulate signaling from the outside of a cell to the inside, but what we know so far is just the tip of the iceberg. This new grant will help us uncover what lies beneath."
Read more...
A new multi-year funding will allow this international group to unravel carbohydrate mysteries. The Consortium for Functional Glycomics was formed in response to the NIGMS announcement that it would provide glue grants to support multi-disciplinary, multi-institutional research projects that would be considered beyond the means of any one group. Currently, more than 30 percent of consortium members are from outside the United States, representing more than 25 countries.
"The long-range goal of the Consortium for Functional Glycomics is to fully understand the mechanisms through which carbohydrate-binding proteins mediate cell function and to share that knowledge with other researchers around the world. We know that carbohydrates aid in the proper trafficking of cells in the body, and that they can modulate signaling from the outside of a cell to the inside, but what we know so far is just the tip of the iceberg. This new grant will help us uncover what lies beneath."
Read more...
Monday, August 14, 2006
Consumer demand for cholesterol lowering products skyrockets
Consumer awareness of foods that curb heart disease and high cholesterol is driving sales of "nutraceuticals" - foods that have specific positive health effects. As nutraceutical sales have risen, approval of new foods and ingredients by American and European authorities have increased as well.
Read More..
Consumer awareness of foods that curb heart disease and high cholesterol is driving sales of "nutraceuticals" - foods that have specific positive health effects. As nutraceutical sales have risen, approval of new foods and ingredients by American and European authorities have increased as well.
Read More..
Thursday, August 03, 2006
Recovered Coach Plans Payback Tourney
Three days after he woke up and had his first appreciation of what had gone wrong and how he was being kept alive, Harry Muir began planning to pay back the people and organizations helping him
On May 10 last year, Muir was throwing batting practice at Labatt Park, preparing to take the Majors into the 2005 season as their field manager. The next day, he woke up desperately ill. By evening, he was in hospital in a coma and for the next 18 days was in a fight for his life.
The former Toronto Blue Jays farm hand had contracted streptococcus toxic shock syndrome. All his organs began to shut down. He was on life support and his heart stopped pumping blood to his extremities. It was feared he would be losing a foot, if not a leg.
Get the full story!
Three days after he woke up and had his first appreciation of what had gone wrong and how he was being kept alive, Harry Muir began planning to pay back the people and organizations helping him
On May 10 last year, Muir was throwing batting practice at Labatt Park, preparing to take the Majors into the 2005 season as their field manager. The next day, he woke up desperately ill. By evening, he was in hospital in a coma and for the next 18 days was in a fight for his life.
The former Toronto Blue Jays farm hand had contracted streptococcus toxic shock syndrome. All his organs began to shut down. He was on life support and his heart stopped pumping blood to his extremities. It was feared he would be losing a foot, if not a leg.
Get the full story!
Monday, July 03, 2006
Toward An Early Diagnostic Test For Ovarian Cancer
In an advance toward eventual development of a much-needed early diagnostic test for ovarian cancer, scientists have identified at least 15 biomarkers for the disease that are present in cancer patients but absent in healthy individuals. Carlito B. Lebrilla and colleagues at the University of California at Davis describe the discovery in a report scheduled for the July 7 issue of the ACS Journal of Proteome Research.
No accurate test for early diagnosis of ovarian cancer currently exists. Many of the 23,000 annual cases are diagnosed only after the disease is advanced and more difficult to treat. Lebrilla's group identified the biomarkers -- which could become the basis of a test -- with an exciting new technology spawned by the human genome project. Called glycomics, it focuses on the structure and function of chains of sugars or "oligosaccharides" that have key functions in the body.
The scientists identified and studied oligosaccharides in substances that ovarian cancer cells shed during growth. Some had never been detected before. Researchers now are moving ahead with studies involving more patients and controls in an effort to find biomarkers that could be used in an ovarian cancer test.
read more...
In an advance toward eventual development of a much-needed early diagnostic test for ovarian cancer, scientists have identified at least 15 biomarkers for the disease that are present in cancer patients but absent in healthy individuals. Carlito B. Lebrilla and colleagues at the University of California at Davis describe the discovery in a report scheduled for the July 7 issue of the ACS Journal of Proteome Research.
No accurate test for early diagnosis of ovarian cancer currently exists. Many of the 23,000 annual cases are diagnosed only after the disease is advanced and more difficult to treat. Lebrilla's group identified the biomarkers -- which could become the basis of a test -- with an exciting new technology spawned by the human genome project. Called glycomics, it focuses on the structure and function of chains of sugars or "oligosaccharides" that have key functions in the body.
The scientists identified and studied oligosaccharides in substances that ovarian cancer cells shed during growth. Some had never been detected before. Researchers now are moving ahead with studies involving more patients and controls in an effort to find biomarkers that could be used in an ovarian cancer test.
read more...
Subscribe to:
Posts (Atom)